This content is restricted.
Brief
"On February 15, 2025, the National Health Surveillance Agency (Anvisa) published a new regulatory framework for Denominações Comuns Brasileiras (DCB). This update includes a resolution and an Instrução Normativa (IN) that establish rules and guidelines for the naming of pharmaceutical substances in Brazil."
Highlights content goes here...
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
